21430171|t|In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
21430171|a|Core pathologies of Alzheimer's disease (AD) are aggregated amyloid-beta peptides (Abeta) and tau, and the latter is also characteristic of diverse neurodegenerative tauopathies. These amyloid lesions provoke microglial activation, and recent neuroimaging technologies have enabled visualization of this response in living brains using radioligands for the peripheral benzodiazepine receptor also known as the 18 kDa translocator protein (TSPO). Here, we elucidated contributions of Abeta and tau deposits to in vivo TSPO signals in pursuit of mechanistic and diagnostic significance of TSPO imaging in AD and other tauopathies. A new antibody to human TSPO revealed induction of TSPO-positive microgliosis by tau fibrils in tauopathy brains. Emergence of TSPO signals before occurrence of brain atrophy and thioflavin-S-positive tau amyloidosis was also demonstrated in living mice transgenic for mutant tau by positron emission tomography (PET) with two classes of TSPO radioligands, [(11)C]AC-5216 and [(18)F]fluoroethoxy-DAA1106. Meanwhile, only modest TSPO elevation was observed in aged mice modeling Abeta plaque deposition, despite the notably enhanced in vivo binding of amyloid radiotracer, [(11)C]Pittsburgh Compound-B, to plaques. In these animals, [(11)C]AC-5216 yielded better TSPO contrasts than [(18)F]fluoroethoxy-DAA1106, supporting the possibility of capturing early neurotoxicity with high-performance TSPO probes. Furthermore, an additional line of mice modeling intraneuronal Abeta accumulation displayed elevated TSPO signals following noticeable neuronal loss, unlike TSPO upregulation heralding massive neuronal death in tauopathy model mice. Our data corroborate the utility of TSPO-PET imaging as a biomarker for tau-triggered toxicity, and as a complement to amyloid scans for diagnostic assessment of tauopathies with and without Abeta pathologies.
21430171	104	109	mouse	Species	10090
21430171	120	139	Alzheimer's disease	Disease	MESH:D000544
21430171	183	202	Alzheimer's disease	Disease	MESH:D000544
21430171	204	206	AD	Disease	MESH:D000544
21430171	246	251	Abeta	Gene	11820
21430171	311	340	neurodegenerative tauopathies	Disease	MESH:D024801
21430171	348	363	amyloid lesions	Disease	MESH:C000718787
21430171	602	606	TSPO	Gene	12257
21430171	646	651	Abeta	Gene	11820
21430171	680	684	TSPO	Gene	12257
21430171	750	754	TSPO	Gene	12257
21430171	766	768	AD	Disease	MESH:D000544
21430171	779	790	tauopathies	Disease	MESH:D024801
21430171	810	815	human	Species	9606
21430171	816	820	TSPO	Gene	706
21430171	843	847	TSPO	Gene	706
21430171	857	869	microgliosis	Disease	
21430171	873	876	tau	Disease	MESH:C536599
21430171	888	897	tauopathy	Disease	MESH:D024801
21430171	919	923	TSPO	Gene	706
21430171	953	966	brain atrophy	Disease	MESH:C566985
21430171	971	983	thioflavin-S	Chemical	MESH:C009462
21430171	993	1008	tau amyloidosis	Disease	MESH:D000686
21430171	1041	1045	mice	Species	10090
21430171	1130	1134	TSPO	Gene	12257
21430171	1149	1163	[(11)C]AC-5216	Chemical	-
21430171	1168	1195	[(18)F]fluoroethoxy-DAA1106	Chemical	-
21430171	1220	1224	TSPO	Gene	12257
21430171	1256	1260	mice	Species	10090
21430171	1270	1275	Abeta	Gene	11820
21430171	1343	1350	amyloid	Disease	MESH:C000718787
21430171	1364	1392	[(11)C]Pittsburgh Compound-B	Chemical	-
21430171	1424	1438	[(11)C]AC-5216	Chemical	-
21430171	1454	1458	TSPO	Gene	12257
21430171	1474	1501	[(18)F]fluoroethoxy-DAA1106	Chemical	-
21430171	1549	1562	neurotoxicity	Disease	MESH:D020258
21430171	1585	1589	TSPO	Gene	12257
21430171	1633	1637	mice	Species	10090
21430171	1661	1666	Abeta	Gene	11820
21430171	1699	1703	TSPO	Gene	12257
21430171	1733	1746	neuronal loss	Disease	MESH:D009410
21430171	1755	1759	TSPO	Gene	12257
21430171	1791	1805	neuronal death	Disease	MESH:D009410
21430171	1809	1818	tauopathy	Disease	MESH:D024801
21430171	1825	1829	mice	Species	10090
21430171	1867	1871	TSPO	Gene	12257
21430171	1917	1925	toxicity	Disease	MESH:D064420
21430171	1950	1957	amyloid	Disease	MESH:C000718787
21430171	1993	2004	tauopathies	Disease	MESH:D024801
21430171	2022	2027	Abeta	Gene	11820
21430171	Association	MESH:D064420	12257
21430171	Association	MESH:D000686	12257
21430171	Association	MESH:D000686	706
21430171	Association	MESH:D009410	12257
21430171	Association	MESH:D000544	11820
21430171	Association	MESH:D020258	12257
21430171	Association	11820	12257
21430171	Association	MESH:D000544	12257
21430171	Positive_Correlation	MESH:C536599	706
21430171	Association	MESH:C566985	706
21430171	Positive_Correlation	MESH:D009410	11820
21430171	Association	MESH:C009462	MESH:D000686

